Susanne Staer

TIAP Voices: From Insight to Innovation — Ensuring Your Discovery Process Includes Discovering Your Customer By: Mobeen Lalani, TIAP Senior Analyst, Technology and Venture Development In the dynamic world of…

Radiant Bio Closes $35 Million Series A Financing to Advance Therapeutic Pipeline with Its Proprietary Multabody™ Platform Funding co-led by the Bill & Melinda Gates Foundation and Amplitude Ventures to…

HDAX Therapeutics Announces First Closing of Oversubscribed US $3.2 (CA $4.3) Million Seed Financing TORONTO--HDAX Therapeutics (“HDAX”), a biotechnology company pioneering a novel approach to targeting HDAC6 for the discovery and…

TIAP Announces First Project to Receive Support Under Newly Launched Critical Technologies Program ScarDx Brings Cutting-Edge Innovation to Fibrosis Detection April 29, 2024 – Toronto, Ontario – Toronto Innovation Acceleration…

TIAP Voices: The Rise of AI and the Convergence with Life Sciences By: Mobeen Lalani, TIAP Analyst, Technology and Venture Development The healthcare industry is undergoing a significant change in…

TIAP Voices: Providing Critical Resources to Realize the Opportunity Before Us By: Prakash Gowd, TIAP Vice President Having recently joined TIAP as Vice President, I wanted to connect with our…

TIAP Features: Fibrocor Therapeutics — Getting to the Core of Fibrosis From its foundational world-class research, its attraction of global investment and global talent to its impending advancement of multiple…

Fibrocor Therapeutics enters into research and development collaboration with McQuade Center for Strategic Research and Development to advance Alport Syndrome program Agreement includes a single digit million US$ upfront payment…

TIAP FEATURES: Vasomune Therapeutics – Tackling Vascular Dysfunction and Boosting Host Defenses From viral and bacterial pneumonia and sepsis, to acute kidney injury, hemorrhagic shock, stroke, and complications associated with…

As part of Ontario’s Critical Technologies initiative, TIAP is pleased to be partnering with OBIO® to offer new support to accelerate the health science industry’s use of cutting-edge technologies. OBIO’s…